You searched for: "*"

The results has been filter on Tags containing Cost-Benefit Analysis.
ANA has found 19 results for you, in 202 ms.
Didn’t find what you were looking for? Try the Advanced Search!

Research papers

Pharmaceutical pricing

With the increasing demands on health care expenditure due to a rise in the proportion of people aged 65 or more. Governments are and will continue to explore ways of reducing costs. It is likely that their focus will be towards the drugs bill rather...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Authors: Diana Grose, Alan J. Bowditch
June 15, 1991

Research papers

Economic evaluation in health care

The objective of this contribution is to briefly outline the broad category of cost- benefit analysis and its potential to provide a meaningful instrument in marketing concepts for pharmaceuticals. First, the incentives for the interest in...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Angela Kempel
June 15, 1991

Research papers

The role of marketing research in identifying the need for cost benefit analysis

The requirement for new prescription drugs to justify their introduction in economic as well as clinical terms is being sought not only at the central, governmental, level but also at the level of the individual hospital and physician practice, where...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: David Dawson
March 6, 1991

Research papers

Judging the efficiency of sponsorship

The central theme of this paper is the point that sponsorship is part of a total communications package and that, if wisely and correctly included, it can add synergy to the entire marketing communications efforts of a given company. As such, it...

Catalogue: ESOMAR Congress 1987
Authors: Peter J. Hayes, Ton Otker
September 1, 1987

Research papers

Corporate sponsorship of arts and sports events in North America

Our analysis looks at costs, benefits, and ways to measure payoffs. Half the firms surveyed take no measurements, but the more astute ones are beginning to measure effectiveness in a number of ways, ranging from simple counts of spectators and...

Catalogue: ESOMAR Congress 1987
Authors: Mark B. Traylor, Philip J. Shuman, Andrew C. Gross
September 1, 1987

Research papers

Socioeconomic benefits of drugs

As a result socioeconomic differentiation may represent additionally to the drug's therapeutic merit-proof a decisive component to achieve a sustainable competitive edge. It represents a strategic element which pharmaceutical companies will have to...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry
Author: J. Wernli
June 15, 1987

Research papers

A model for a cost-benefit analysis of a new pharmaceutical

There is growing clamour of late that the evaluation of new pharmaceuticals should not only contain analysis of safety and efficacy, but also elements of economic analysis. The reason: the quality of present-day background material is such that it...

Catalogue: Seminar 1987: Pricing And Forecasting In Pharmaceutical Industry
Author: P. Hertzman
June 15, 1987

Research papers

A comparative assessment of the costs and benefits of single location and multiple location telephone interviewing for multi-national research

The aim of this paper is to assess the comparative costs and benefits of single location and multiple location telephone interviewing for multi-national research projects. Special attention is paid to studies involving two or more European countries,...

Catalogue: ICC/ESOMAR Symposium 1984: International Marketing Research
Author: Nick H. Sparrow
Company: Marplan Forschungsgesellschaft mbH
June 15, 1984

Research papers

More value from image research for less money

Since the introduction of the image concept to marketing a significant part of marketing research budgets is spent on image research. Stimulated by the necessity to adapt existing research techniques to research by telephone, NSS, in co-operation...

Catalogue: ESOMAR Congress 1984: What We Have Learned From The Recession
Authors: L. J. van der Herberg, Peter H. van Westendorp
June 15, 1984